Article Details

Phathom Pharmaceuticals Receives Buy Rating and Shows Positive Momentum in ... - Best Stocks

Retrieved on: 2023-09-11 21:08:10

Tags for this article:

Click the tags to see associated articles and topics

Phathom Pharmaceuticals Receives Buy Rating and Shows Positive Momentum in ... - Best Stocks. View article details on hiswai:

Excerpt

As a biopharmaceutical company, Phathom Pharmaceuticals focuses on developing and commercializing treatments for gastrointestinal diseases.

Article found on: beststocks.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up